Introduction
Priapism is a painful erection outlasting sexual desire, that is not spontaneously reversible and always requires therapy. The reasons may be different: in about half of the cases, hematologicalvascular disorders, neurogenic -psychiatric deviations, neoplasms, metabolic malfunctions, chronic inflammations, trauma and pharmaceuticals are considered to induce priapism. 1, 2 Since the introduction of corpora cavernosa autoinjection therapy (CCAT) for patients with erectile failure, the causes of priapism have been mainly pharmaco-induced. 1 Heparin induced priapism seems to occur very rarely. Less than 20 cases have been described during the last 30 y. 3 -7 In general, the rare arterial, non-ischemic highflow priapism is differentiated from the more frequent, anoxic, ischemic low-flow priapism. 1, 8 Their pathophysiology and therapy differ greatly: High-flow priapism is caused by an increased influx of blood into the corpora cavernosa, possibly due to a traumatic, arterio-venous fistula or the injection of vasoactive substances. 1, 8 It mostly develops following sexual stimulation or nocturnal erections. Lowflow priapism is caused by an obstruction of the penile venous system. 1, 8 Hypoxia develops 2 -3 h later as a result of the stasis of intracavernosal blood. Additionally, reduced oxygen saturation causes damage to the vascular endothel and cavernosal smooth muscles and resulting in considerable pain. If the low blood flow and the hypoxic conditions continue, fibrosis of the corpora cavernosa develops after 6 -36 h, finally leading to permanent erectile dysfunction. 1, 8 A careful diagnostic work-up, that is suitable to discern the two types of priapism, is a prerequisite for therapy with good prospects. 9 In addition to the patient's history, which should include other diseases as well as pharmacotherapy and traumatic incidents, the clinical examination provides important hints: pain on palpation as well as the inability of impression are signs of low-flow priapism, whereas a more fluctuating palpation is typical for the high-flow priapism. In low-flow priapism, the glans penis is usually soft while the corpora cavernosa are absolutely rigid. 1 However, verification of the diagnosis can only be obtained by aspiration of intracavernosal blood and subsequent blood gas analysis. 1, 9 Results showing metabolism with a pO 2 of less than 60 mmHg, more than 70 mmHg pCO 2 and pH-values below 7.0 underline low-flow priapism; inverse results point to arterial priapism. 1, 9 Additionally, examination of the penile blood flow with colour duplex sonography provides adequate differentiation. An uncontrolled blood flow into the corpora cavernosa, especially after trauma, can be detected in the case of high-flow priapism. On the other hand, low-flow-priapism can be confirmed by the occurrence of the minimal peak flow velocity. 9 Due to the different pathophysiological mechanisms the urgency of therapeutic intervention varies. In the case of a high-flow priapism based on a traumatic arteriovenous fistula, it is possible to wait for several days before commencing therapy. 1 CCAT-induced arterial priapism changes into lowflow priapism after a few hours; at this time the therapeutic intervention has to start. Different authors determine the point of no return to be between 4 and 12 h after onset of the erection. 1, 8, 9 In every case of low-flow priapism, treatment has to start immediately.
The application of sedatives as well as ketamine hydrochloride has been proposed as conservative treatment. 1 However, conservative therapy often proves to be insufficient. Thus initial aspiration of 200 ml blood out of the corpora cavernosa and the injection of a-adrenergic agonists seem to be the pharmaceutical treatment of choice because of the less serious side effects. 1 But there have been reports of hypertension, tachycardia and arrhythmia in this connection requiring a cardial monitoring of the patient during therapy. If the initial treatment fails, the antidote should be applied for a second time 30 min later. If a-stimulation does not lead to a successful outcome, this may be due to the fact that there is no contractile smooth muscle left or that intracavernosal fibrosis has already begun. 1, 8 Surgical procedures with the creation of different shunts then have to be performed. The aim of surgical therapy is to provide a shunt between the corpora cavernosa and either the glans penis, 10 the corpus spongiosum or a vein to bypass the obstructed venoocclusive mechanism. 1 Today, the Ebbehøj-Winter shunt 10 seems to be accepted as the initial surgical therapy of choice due to its low invasiveness, simple procedure and high efficacy.
Case report
A 39-y-old patient was hospitalized with stenocordia. He had already received nitrate, heparin and acetylsalicylic acid in the outpatient department. Clinically suspected myocardial infarction could not be confirmed by laboratory methods or electrocardiography. Nevertheless, the patient was treated with 20000 IE=day heparin-sodium (Ratiopharm, Germany), glycerol nitrate, magnesium carbonate, calcium, acetylsalicylic acid, pentoxifylline and diazepam. In the evening the patient complained about pain in his penis. There was evidence of priapism, which had begun 2 h after the application of heparin and had persisted for the previous 15 h. The infusion of heparin was stopped immediately. After a short period of detumescence, there were further persistent erections. Thus the patient was transferred to our Department of Urology. When the patient arrived, priapism had already persisted for 36 h. After puncture of the cavernosal bodies, gas analysis of aspirated intracavernosal blood produced the following results: pO 2 22.7 mmHg, pCO 2 118.0 mmHg and pH 6.886 -clearly demonstrating low-flow priapism. Leukemia was excluded, and there was no hint of thrombophilia. A corporospongiosus shunt was constructed according to the technique of Ebbehøj-Winter. 10 On the next day, because of incomplete detumescence, we extended the shunt removing the corporal tips to perform a wide communication between the glans penis and the corpora cavernosa. After this procedure priapism was finally resolved. Rigidity and tumescence were greatly reduced postoperatively; because of intracavernosal thrombosis, however some residual rigidity remained.
After being released from hospital, the patient was seen regularly in our outpatient department. He complained about erections of minimal tumescence, so that he was unable to have sexual intercourse. Six months later the patient was re-evaluated by pharmaco-duplex ultrasound, cavernosography and cavernosometry. After the intracavernosal injection of 20 mg PGE 1, the velocity of blood flow in the arteria profunda penis amounted to 29 cm=s on each side, and a moderate tumescence without rigidity developed. Cavernosography indicated a corporoglandular shunt, a spongiosal shunt, a leakage into the dorsal veins and numerous recesses of contrast medium caused by older thrombotic material or fibrotic alterations (Figure 1 ). Due to excessive fibrosis, cavernosometry failed to give exact measurements. Rigidity only appeared in the distal penis.
Intracavernosal therapy with 100 mg sildenafil (Viagra TM ) and 20 mg prostaglandin E 1 failed. Psychosomatic examination revealed a reactive depression. Finally, a hydraulic prosthesis (type AMS 700 CX) was implanted 14 months after the primary incident. On this occasion cavernosal tissue was extracted and examined histologically. Thrombosis and interstitial fibrosis were detected. Furthermore, histological signs of hemorrhage were demonstrated -recognizable by iron storage in numerous macrophages. Inside fibrotic areas growth of capillaries could be identified as well as proliferation of fibroblasts and scars without any vessels were visible.
Discussion
In the last 30 y the appearance of priapism following the application of heparin has been mentioned only about 20 times. 3 -7 None of the articles were able to clarify the pathophysiological mechanism. It was
Heparin-induced priapism
Th Bschleipfer et al suggested that the occurrence of heparin-dependent antiplatelet-antibodies might be responsible for the development of platelet aggregates, that could lead to an altered penile blood flow. 6 In nearly all of the cases presented in the literature, 3 -7 conservative treatment is described as being insufficient. The aspiration of intracavernosal blood and surgery were necessary to achieve detumescence. Our patient reported pain 15 h after the onset of erection. It is not clear whether in the case of heparin-induced priapism initial high-flow priapism turns into low-flow priapism later, even though this kind of priapism was proved by blood gas analysis of aspirated intracavernosal blood. The rather late appearance of pain supports this assumption, but so far it has not been possible to detect a high-flow priapism.
Critical examination of our histological preparations showed iron storage in numerous macrophages as residual signs of bleeding, but also fibrotically changed areas with proliferation of fibroblasts and areas with increased occurrence of capillary vessels.
These pathological results supported the assumption that thrombosis is involved in the development of priapism as an anticoagulatory adverse effect. Similarly, bleeding into the corpus cavernosum with subsequent organisation of the hematoma and formation of scars may also contribute to this condition.
In accordance with the usual diagnostic-therapeutical cascade after puncture of the corpus cavenosum and aspiration, instillation of etilefrine (Effortil TM ) was also tried in our case. Blood gas analysis confirmed the diagnosis of low-flow priapism. In order to terminate priapism as quickly as possible and to minimize subsequent damage, surgery was performed immediately. However, fibrosis of the corpora cavernosa was inevitable after an erection lasting for 36 h. This resulted in erectile dysfunction, which could not be treated neither by sildenafil nor by PGE 1 -autoinjection. Thus, a penile prosthesis was implanted. This was seen as the last attempt to 'restore' erectile function. 
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